Ransohoff R - Search Results

1

Axonal pathology in multiple sclerosis: relationship to neurologic disability.

Trapp BD, Ransohoff R, Rudick R. Trapp BD, et al. Among authors: ransohoff r. Curr Opin Neurol. 1999 Jun;12(3):295-302. doi: 10.1097/00019052-199906000-00008. Curr Opin Neurol. 1999. PMID: 10499174 Review.

2

Defining interferon beta response status in multiple sclerosis patients.

Rudick RA, Lee JC, Simon J, Ransohoff RM, Fisher E. Rudick RA, et al. Ann Neurol. 2004 Oct;56(4):548-55. doi: 10.1002/ana.20224. Ann Neurol. 2004. PMID: 15389896 Clinical Trial.

3

Cortical demyelination in PML and MS: Similarities and differences.

Moll NM, Rietsch AM, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS, Trapp BD, Ransohoff RM. Moll NM, et al. Neurology. 2008 Jan 29;70(5):336-43. doi: 10.1212/01.WNL.0000284601.54436.e4. Neurology. 2008. PMID: 17914063

4

Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis.

Moll NM, Cossoy MB, Fisher E, Staugaitis SM, Tucky BH, Rietsch AM, Chang A, Fox RJ, Trapp BD, Ransohoff RM. Moll NM, et al. Arch Neurol. 2009 Jan;66(1):44-53. doi: 10.1001/archneurol.2008.512. Arch Neurol. 2009. PMID: 19139298 Free PMC article.

5

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD. Wujek JR, et al. Among authors: ransohoff rm. J Neuropathol Exp Neurol. 2002 Jan;61(1):23-32. doi: 10.1093/jnen/61.1.23. J Neuropathol Exp Neurol. 2002. PMID: 11829341

6

VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions.

Peterson JW, Bö L, Mörk S, Chang A, Ransohoff RM, Trapp BD. Peterson JW, et al. J Neuropathol Exp Neurol. 2002 Jun;61(6):539-46. doi: 10.1093/jnen/61.6.539. J Neuropathol Exp Neurol. 2002. PMID: 12071637

7

Chemokine receptors as biomarkers in multiple sclerosis.

Fox RJ, Kivisäkk P, Lee JC, Tucky B, Lucchinetti C, Rudick RA, Ransohoff RM. Fox RJ, et al. Dis Markers. 2006;22(4):227-33. doi: 10.1155/2006/694283. Dis Markers. 2006. PMID: 17124344 Free PMC article.

8

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis.

Rudick RA, Rani MR, Xu Y, Lee JC, Na J, Shrock J, Josyula A, Fisher E, Ransohoff RM. Rudick RA, et al. Among authors: ransohoff rm. PLoS One. 2011;6(5):e19262. doi: 10.1371/journal.pone.0019262. Epub 2011 May 13. PLoS One. 2011. PMID: 21602934 Free PMC article. Clinical Trial.

9

The role of cell type-specific responses in IFN-β therapy of multiple sclerosis.

Zula JA, Green HC, Ransohoff RM, Rudick RA, Stark GR, van Boxel-Dezaire AH. Zula JA, et al. Among authors: ransohoff rm. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19689-94. doi: 10.1073/pnas.1117347108. Epub 2011 Nov 21. Proc Natl Acad Sci U S A. 2011. PMID: 22106296 Free PMC article.

10

Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons.

Ohno N, Chiang H, Mahad DJ, Kidd GJ, Liu L, Ransohoff RM, Sheng ZH, Komuro H, Trapp BD. Ohno N, et al. Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9953-8. doi: 10.1073/pnas.1401155111. Epub 2014 Jun 23. Proc Natl Acad Sci U S A. 2014. PMID: 24958879 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters